🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Primary Antibody Deficiency Disorders

Exercise Intervention and Immunodeficiency NCT07698197NA2 sites📍 Milford📍 North Haven Yale University · Tests: App-based exercise intervention A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs). NCT04319367Phase 212 sites📍 Aarhus📍 Brighton📍 Edinburgh Imperial College London · Tests: Investigational Medicinal Product Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity NCT04339777Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Busulfan test dose, Fludarabine, Busulfan, Alemtuzumab, Total body Irradiation Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer NCT07851025Phase 3186 sites📍 Tampa📍 Baltimore📍 Billings AstraZeneca · Tests: Torvutatug samrotecan, Bevacizumab A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency NCT06565078n/a1 site📍 Tokyo Takeda · Tests: Immune Globulin Subcutaneous (Human), 20% Solution Natural History of Bronchiectasis NCT00943514n/a1 site📍 Bethesda National Heart, Lung, and Blood Institute (NHLBI) Safety and Efficacy of PD-1 ± mFOLFOX6 Neoadjuvant Therapy in Local Advanced sMPCC NCT06002789Phase 21 site📍 Guangzhou Sixth Affiliated Hospital, Sun Yat-sen University · Tests: MSI-H/MSS (dMMR/pMMR) mixed sMPCC: combination of mFOLFOX6+PD-1 monoclonal antibody neoadjuvant therapy, All-MSI-H (dMM… Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) NCT07346859Phase 312 sites📍 Cherkasy📍 Chernivtsi📍 Ivano-Frankivsk Biopharma Plasma LLC · Tests: BP-SCIG 20% Institutional Registry of Rare Diseases NCT06573723n/a1 site📍 Buenos Aires Hospital Italiano de Buenos Aires Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) NCT07284641Phase 21 site📍 Pittsburgh Paul Szabolcs · Tests: Hematopoietic stem cell transplant (HSCT) Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease NCT05193552Phase 41 site📍 Birmingham University of Alabama at Birmingham · Tests: Hizentra Immune Regulation in Patients With Common Variable Immunodeficiency and Related Inborn Errors of Immunity (IEI) NCT00001244n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies NCT02579967Phase 22 sites📍 Bethesda📍 Minneapolis National Cancer Institute (NCI) · Tests: Immunosuppression Only Conditioning -Closed with amendment L, Reduced Intensity Conditioning, Myeloablative Conditionin… V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency NCT06954441Phase 31 site📍 Recife On Pharma Importadora, Exportadora e Distribuidora de Medic… · Tests: Intravenous immunoglobulin (IVIG) Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control NCT05300035Phase 217 sites📍 Bobigny📍 Clamart📍 Clichy ANRS, Emerging Infectious Diseases · Tests: Recombinant human monoclonal antibody (bNAbs), Placebo Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia NCT06976476Phase 29 sites📍 Atlanta📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: IgPro20 National Registry of Rare Kidney Diseases NCT06065852n/a1 site📍 Bristol UK Kidney Association
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy